Increased body mass index linked to decreased neutralizing antibody titers of inactivated SARS‐CoV‐2 vaccine in healthcare workers

OBJECTIVE: Obesity is an important risk factor for COVID‐19. However, whether obesity affects SARS‐CoV‐2 antibody production is unclear. This study aimed to identify the influence of obesity on neutralizing antibody production of an inactivated SARS‐CoV‐2 vaccine to better guide vaccination strategi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Juan, Zhao, Mingcai, Zhao, Yongmei, Dong, Wenjuan, Huang, Xuemei, Zhang, Shaocheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
SPECIAL SECTION: OBESITY IN ASIA
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348346/
https://www.ncbi.nlm.nih.gov/pubmed/35941911
http://dx.doi.org/10.1002/osp4.626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348346/
https://www.ncbi.nlm.nih.gov/pubmed/35941911
http://dx.doi.org/10.1002/osp4.626

Ejemplares similares